S. Gill

APhase I Biodistribution and PharmacokineticTrial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-YAntigen

A. Scott, M. Brechbiel, A. Papenfuss, 2007 .

A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen

A. Scott, M. Brechbiel, A. Papenfuss, 2007, Clinical Cancer Research.

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

A. Scott, M. Brechbiel, A. Burgess, 2007, Proceedings of the National Academy of Sciences.

Role of Low-dose, Noncontrast Computed Tomography from Integrated Positron Emission Tomography/Computed Tomography in Evaluating Incidental 2-Deoxy-2-[F-18]fluoro-d-glucose-avid Colon Lesions

S. Berlangieri, G. O'Keefe, N. Tebbutt, 2007, Molecular Imaging and Biology.

A phase I clinical trial with monoclonal antibody ch 806 targeting transitional state and mutant epidermal growth factor receptors

A. Scott, M. Brechbiel, A. Papenfuss, 2007 .

Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine

A. Scott, G. O'Keefe, N. Tebbutt, 2014, The Journal of Nuclear Medicine.

Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine

A. Scott, G. O'Keefe, N. Tebbutt, 2014, The Journal of Nuclear Medicine.